Correlation Between Tempest Therapeutics and Incyte
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Incyte, you can compare the effects of market volatilities on Tempest Therapeutics and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Incyte.
Diversification Opportunities for Tempest Therapeutics and Incyte
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tempest and Incyte is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Incyte go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Incyte
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 26.95 times more return on investment than Incyte. However, Tempest Therapeutics is 26.95 times more volatile than Incyte. It trades about 0.03 of its potential returns per unit of risk. Incyte is currently generating about -0.01 per unit of risk. If you would invest 165.00 in Tempest Therapeutics on August 24, 2024 and sell it today you would lose (74.00) from holding Tempest Therapeutics or give up 44.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Incyte
Performance |
| Timeline |
| Tempest Therapeutics |
| Incyte |
Tempest Therapeutics and Incyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Incyte
The main advantage of trading using opposite Tempest Therapeutics and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.| Tempest Therapeutics vs. Lyra Therapeutics | Tempest Therapeutics vs. Hookipa Pharma | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. SAB Biotherapeutics |
| Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges |